High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: The first follow up study over two years

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Serbecic, Nermin ^a   Aboul Enein, Fahmy ^b   Beutelspacher, Sven C ^c   Vass, Clemens ^a   Kristoferitsch, Wolfgang ^b   Lassmann, Hans ^a   Reitner, Andreas ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DANUBE HOSPITAL   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; ONSET AGE; OPTICAL RESOLUTION; PROSPECTIVE STUDY; RELAPSE; RETINA NERVE FIBER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS; ADOLESCENT; DEMOGRAPHY; METHODOLOGY; MIDDLE AGED; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA;

ADOLESCENT; ADULT; DEMOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 79956099882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019843     Document Type: Article

References (35)

1. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.
2. Goodin DS, (2009) The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 4: e4565.
3. Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler B, et al. (2010) Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One 5: e13568.
4. Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, et al. (2008) Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 3: e2559.
5. Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, et al. (2009) IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 4: e7638.
6. Brettschneider J, Czerwoniak A, Senel M, Fang L, Kassubek J, et al. (2010) The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One 5: e11986.
7. Stoop MP, Singh V, Dekker LJ, Titulaer MK, Stingl C, et al. (2010) Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis. PLoS One 5: e12442.
8. Ban M, Elson J, Walton A, Turnbull D, Compston A, et al. (2008) Investigation of the role of mitochondrial DNA in multiple sclerosis susceptibility. PLoS One 3: e2891.
9. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, et al. (2010) MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 5: e12132.
10. Gilmore CP, Cottrell DA, Scolding NJ, Wingerchuk DM, Weinshenker BG, et al. (2010) A window of opportunity for no treatment in early multiple sclerosis? Mult Scler 16: 756-759.
11. Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, et al. (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214: 665-670.
12. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC, (2006) The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 129: 584-594.
13. Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, et al. (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131: 808-817.
14. Optic Neuritis Study Group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65: 727-732.
15. Mostert JP, Koch MW, Steen C, Heersema DJ, De Groot JC, et al. (2010) T2 lesions and rate of progression of disability in multiple sclerosis. Eur J Neurol 17: 1471-1475.
16. Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W, (2010) Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. PLoS One 5: e11625.
17. Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, et al. (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133: 1900-1913.
18. Lassmann H, Brück W, Lucchinetti CF, (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-218.
19. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, et al. (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4: 664-675.
20. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, et al. (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9: 921-932.
21. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, et al. (2008) An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 131: 277-287.
22. Serbecic N, Aboul-Enein F, Beutelspacher SC, Graf M, Kircher K, et al. (2010) Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations. PLoS One 2010 5: e13877.
23. Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, et al. (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67: 749-760.
24. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, et al. (2010) A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 257: 1083-1091.
25. Serbecic N, Beutelspacher SC, Kircher K, Reitner A, Schmidt-Erfurth U, (2010) Interpretation of RNFLT values in multiple sclerosis-associated acute optic neuritis using high-resolution SD-OCT device. Acta Ophthalmol 2010 doi:10.1111/j.1755-3768.2010.02013.x.
26. Serbecic N, Beutelspacher SC, Aboul-Enein FC, Kircher K, Reitner A, et al. (2010) Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography. Br J Ophthalmol 2010 doi:10.1136/bjo.2010.186221.
27. Khanifar AA, Parlitsis GJ, Ehrlich JR, Aaker GD, D'Amico DJ, et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol 2010; 4: 1007-13.
28. Feigin V, Kurtzke JF, Korczyn A, Beghi E, Brown A, (2009) Bridging the gap between experimental and non-experimental neuroepidemiology, and ultimately- between neuroepidemiological research and practice: round table discussion at the First International Congress on Clinical Neurology and Epidemiology. Neuroepidemiology 33: 296-304.
29. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, et al. (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50: 3432-3437.
30. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
31. Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, et al. (2010) Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One 5: e10455.
32. Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W, (2010) Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol 31: 76-79.
33. Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, et al. (2009) Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 19: 2535-2543.
34. Bendschneider D, Tornow RP, Horn FK, Laemmer R, Roessler CW, et al. (2010) Retinal nerve fiber layer thickness in normals measured by spectral domain OCT. J Glaucoma 19: 475-482.
35. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R, et al. (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133: 1591-1601.